Arkolith/Insider Trading/ORIC/Form 4

Piscitelli Dominic

Chief Financial OfficerOric Pharmaceuticals, Inc. (ORIC) · full profile →Form 4 · filed Oct 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$160K
Net Open-Market Flow
-$160K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 6, 2025Sell(S)11K$14.52$160K48K
Oct 6, 2025Option exercise(M)11K$4.36$48K59K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 6, 2025Option exercise(M)11K—$0197K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001695028-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML